Blog

How Alpha Analyst is redefining investment research. Insights, team perspectives, and the latest on building AI for finance.

STRC Preferred Stock: What the Record Volume Means (And What to Check)

STRC Preferred Stock: What the Record Volume Means (And What to Check)

A due-diligence playbook for Strategy’s variable-rate “Stretch” preferred—structure, cash dividend mechanics, and filing-driven risk checks.

Galaxy Digital (GLXY) and the Crypto Market Structure Bill: What Alex Thorn’s Take Signals

Galaxy Digital (GLXY) and the Crypto Market Structure Bill: What Alex Thorn’s Take Signals

A timely policy-to-prices read-through, key open questions, and a practical monitoring checklist for investors

Amgen (AMGN) Deep Dive: Products, Pipeline, and Key Risks

Amgen (AMGN) Deep Dive: Products, Pipeline, and Key Risks

A practical equity-research playbook for underwriting the next leg of growth, margin durability, and biosimilar exposure

Daikin Industries (6367): A Deep-Dive Equity Research Playbook

Daikin Industries (6367): A Deep-Dive Equity Research Playbook

Business model, segment drivers, key risks, and how to build a thesis faster in Alpha Analyst

Panasonic (6752) Deep Dive: Segments, Strategy, and Key Watch Items

Panasonic (6752) Deep Dive: Segments, Strategy, and Key Watch Items

A filing-driven look at Panasonic Holdings’ business mix, portfolio moves, and the debates that matter for investors

Gilead Sciences (GILD) Deep Dive: Business, Moats, and Key Risks

Gilead Sciences (GILD) Deep Dive: Business, Moats, and Key Risks

A practical investor framework for underwriting Gilead’s HIV-led cash flows, oncology optionality, and policy-driven headwinds

Applied Materials (AMAT) deep dive: segments, cycle drivers, and risks

Applied Materials (AMAT) deep dive: segments, cycle drivers, and risks

A fundamentals-first playbook for underwriting the leading wafer fab equipment franchise

ATOS Stock Jumped: FDA Orphan Drug Designation for (Z)-Endoxifen Explained

ATOS Stock Jumped: FDA Orphan Drug Designation for (Z)-Endoxifen Explained

What the FDA’s ODD signal can mean, what it doesn’t mean, and how to verify the catalyst in filings fast

Wegovy 7.2 mg Dose Approval: What It Means for Novo Nordisk (NVO)

Wegovy 7.2 mg Dose Approval: What It Means for Novo Nordisk (NVO)

MHRA’s updated Wegovy dosing guidance, who it applies to, and an investor checklist to track what changes next